Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors

Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors

US Patent 6916807 · Granted Jul 12, 2005

Estimated economic value: $283,397,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CDK2 inhibitors2023
CDK2 inhibitors2023
CDK2/4/6 inhibitors2022
Anti-proliferative agents for treating PAH2021
CDK2 inhibitors2021
CDK2/4/6 inhibitors2020
Sulfonyl amide derivatives for the treatment of abnormal cell growth2019
CDK2/4/6 inhibitors2019
Sulfonyl amide derivatives for the treatment of abnormal cell growth2013
Pyrazolospiroketone acetyl-CoA carboxylase inhibitors2012
Sulfonyl amide derivatives for the treatment of abnormal cell growth2012
Sulfonyl amide derivatives for the treatment of abnormal cell growth2011